Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer

BMC Cancer

Table 2 Total expression levels of candidate genes in non-malignant and prostate cancer tissues.

Gene	Total Expression in non-malignant prostate tissues	Total Expression in prostate cancer tissues	Value
JAZF1	0.82 (1.7)	0.83 (0.97)	0.185
SLC22A3	1.01 (1.42)	0.48 (0.75)	0.015
*LMTK2*	*1.10 (0.77)*	*0.35 (0.30)*	*2.4 × 10* ^-7
MSMB	95.3 (326.3)	13.5 (90.9)	0.156
HNF1B	63.0 (106.8)	37.3 (56.0)	0.175
MYEOV	0.07 (0.15)	0.08 (0.15)	0.655
CTBP2	3.35 (2.54)	2.1 (1.6)	0.008

Gene expression levels are analysed relative to the beta 2 microglobulin (B2M) and beta glucorinidase (GUSB) genes, and normalised to the average value in the non-malignant samples. The interquartile range is given in parentheses. A P value of 0.007 (P = 0.05/n° of tests) was taken to indicate statistical significance following correction for multiple testing (7 independent tests). Statistically significant results are indicated in bold italic type.

ISSN: 1471-2407